Cooperation between insulin and leptin in the modulation of vascular tone

Hypertension

Volumn 42, Issue 2, 2003, Pages 166-170

  Vecchione, Carmine ^a   Aretini, Alessandra ^a   Maffei, Angelo ^a   Marino, Gennaro ^a   Selvetella, Giulio ^a   Poulet, Roberta ^a   Trimarco, Valentina ^a   Frati, Giacomo ^a   Lembo, Giuseppe ^a,b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Endothelium derived factors; Insulin; Leptin; Nitric oxide synthase; Phosphorylation; Vasorelaxation

Indexed keywords

4,5 DIAMINOFLUORESCEIN; ACETYLCHOLINE; FLUORESCEIN DERIVATIVE; INSULIN; LEPTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; SERINE; THREONINE; UNCLASSIFIED DRUG; 4,5-DIAMINOFLUORESCEIN; AKT1 PROTEIN, RAT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUORESCEIN; FLUORESCENT DYE; NOS3 PROTEIN, RAT; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; VASODILATOR AGENT;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG POTENTIATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; VASODILATATION; WESTERN BLOTTING; ANIMAL; AORTA; BIOSYNTHESIS; CULTURE TECHNIQUE; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; WISTAR KYOTO RAT;

ANIMALS; AORTA; BLOTTING, WESTERN; CULTURE TECHNIQUES; DRUG SYNERGISM; FLUORESCEIN; FLUORESCENT DYES; INSULIN; LEPTIN; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED WKY; VASODILATION; VASODILATOR AGENTS;

EID: 0042767516     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000082806.73530.68     Document Type: Article

References (27)

1. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
2. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S-115S.
3. Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC, Russo P, Della Valle E, Strazzullo P. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res. 2003;11:160-166.
4. Kazumi T, Kawaguchi A, Katoh J, Iwahashi M, Yoshino G. Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index. J. Hypertens. 1999;17:1451-1455.
5. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 1997;96:4104-4113.
6. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30:619-623.
7. Lembo G, Vecchone C, Fratta L, Marino G, Trimarco V, d'Amati G, Trimarco B. Leptin induces a direct vasodilation through distinct endothelial mechanisms. Diabetes. 2000;49:293-297.
8. 1179. J Biol Chem. 2001;276:30392-30398.
9. Zeng G, Nystrom FH, Ravichandran LV, Li-Na Cong, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, P13-kinase, and Akt in insulin signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation. 2000;101:1539-1545.
10. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597-601.
11. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601-605.
12. Vecchione C, Maffei A, Colella S, Aretini A, Poulet R, Frati G, Gentile MT, Fratta L, Trimarco V, Trimarco B, Lembo G. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168-173.
13. Szanto I, Kahn CR. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA. 2000;97:2355-2360.
14. Kim YB, Uotani S, Pierroz DD, Flier JS, Kahn BB. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology. 2000;141:2328-2339.
15. Peterson KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, Depaoli AM, Taylor SI, Gorden P, Shulman GI. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 2002;109:1345-1350.
16. Cardillo C, Kilcoyne CM, Nambi SS, Cannon RO 3rd, Quon MJ, Panza JA. Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension. 1998;32:740-745.
17. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
18. Wu HY, Jeng YY, Yue CJ, Chyu KY, Hsueh WA, Chan TM. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes. 1994;43:1027-1032.
19. Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension. 1995;26:290-293.
20. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1995;94:1172-1179.
21. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994;94:2511-2515.
22. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trend Biochem Sci. 2001;25:657-664.
23. Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K; Henry RR. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes. 2002;51:2190-2198.
24. Li Y, Dowbenko D, Lasky LA. Akt/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. 2002;277:11352-11361.
25. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J Biol Chem. 1998;273:30336-30343.
26. Oltman CL, Kane NL, Gutterman DD, Bar RS, Dellsperger KC. Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size. Am J Physiol Endocrinol Metab. 2000;279:E176-E181.
27. Scotland RS, Morales-Ruiz M, Chen Y, Yu J, Rudic RD, Fulton D, Gratton JP, Sessa WC. Functional reconstitution of endothelial nitric oxide synthase reveals the importance of serine 1179 in endothelium-dependent vasomotion. Circ Res. 2002;90:904-10.